NOMURA Co., Ltd.
NOMURA Co., Ltd. (9716.T) Financial Performance & Income Statement Overview
Review NOMURA Co., Ltd. (9716.T) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
NOMURA Co., Ltd. (9716.T) Income Statement & Financial Overview
Analyze NOMURA Co., Ltd.’s 9716.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $56.02B | $36.29B | $28.88B | $29.07B |
| Cost of Revenue | $44.59B | $30.08B | $24.24B | $23.97B |
| Gross Profit | $11.44B | $6.21B | $4.63B | $5.10B |
| Gross Profit Ratio | $0.20 | $0.17 | $0.16 | $0.18 |
| R&D Expenses | $0.00 | $0.00 | $30.00M | $16.00M |
| SG&A Expenses | $5.62B | $4.57B | $4.19B | $4.06B |
| Operating Expenses | $5.62B | $4.57B | $4.22B | $4.07B |
| Total Costs & Expenses | $50.21B | $34.65B | $28.46B | $28.04B |
| Interest Income | $14.00M | $0.00 | $4.00M | $1.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $326.00M | $312.75M | $310.00M | $302.00M |
| EBITDA | $6.17B | $1.95B | $704.00M | $1.34B |
| EBITDA Ratio | $0.11 | $0.05 | $0.02 | $0.05 |
| Operating Income | $5.81B | $1.64B | $417.00M | $1.03B |
| Operating Income Ratio | $0.10 | $0.05 | $0.01 | $0.04 |
| Other Income/Expenses (Net) | $36.00M | $304.00M | -$26.00M | $97.00M |
| Income Before Tax | $5.85B | $1.95B | $391.00M | $1.12B |
| Income Before Tax Ratio | $0.10 | $0.05 | $0.01 | $0.04 |
| Income Tax Expense | $1.33B | $563.00M | $146.00M | $516.00M |
| Net Income | $4.52B | $1.38B | $245.00M | $606.00M |
| Net Income Ratio | $0.08 | $0.04 | $0.008 | $0.02 |
| EPS | $40.55 | $12.40 | $2.20 | $5.44 |
| Diluted EPS | $40.55 | $12.41 | $2.20 | $5.44 |
| Weighted Avg Shares Outstanding | $111.51M | $111.59M | $111.61M | $111.42M |
| Weighted Avg Shares Outstanding (Diluted) | $111.51M | $111.54M | $111.61M | $111.42M |
The company's financials show resilient growth, with revenue advancing from $29.07B in Q1 2024 to $56.02B in Q4 2024. Gross profit remained healthy with margins at 20% in Q4 2024 compared to 18% in Q1 2024. Operating income hit $5.81B last quarter, sustaining a consistent 10% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $6.17B. Net income rose to $4.52B, while earnings per share reached $40.55. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan